Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access


Med J Bakirkoy. 2014; 10(2): 75-77

Radioiodine therapy for hyperthyroidism in a patient with end-stage renal disease on hemodialysis: case report

Müge Tamam, Mehmet Mülazımoğlu, Nurcan Edis, Ercan Uyanık, Tevfik Özpaçacı.

Toxic nodular goiter is a rare entity in end-stage renal disaese (ESRD) patients. In ESRD patients, hypothyroidism is generally seen, whereas hyperthyroidism is rare. Treatment with radioactive iodine (RAI) may be necessary for hyperthyroidism in patients with end-stage renal disease who require haemodialysis. Because RAI is cleared mainly by the kidneys in patients with normal renal function, many problems may (issues) arise in patients who are on hemodialysis but require RAI treatment. We present an ESRD patient with hyperthyroidism who is receiving hemodialysis treated with radioiodine therapy.

Key words: Hyperthyroidism, hemodialysis, radioiodine theraphy

Hemodiyalize giren son dönem böbrek hastalığı olan hipertiroidili bir olguda radyoaktif iyot ile tedavi: Olgu sunumu

Toksik nodüler guatr son dönem böbrek yetmezliği hastalığında nadir görülen bir durumdur. Son dönem böbrek yetmezliği olan hastalarda, genellikle hipotiroidizm görülürken hipertiroidi nadirdir. Hemodiyaliz ile tedavi edilen son dönem böbrek hastalığı olan hipertiroidi hastalarında radyoaktif iyot (RAI) tedavisi gerekli olabilir. RAI, özellikle böbrek fonksiyonu normal olan hastalarda böbrekler tarafından temizlendiğinden, hemodiyaliz hastası olup RAI tedavisi alanlarda çeşitli problemler ortaya çıkabilmektedir. Hipertiroidi hastalığı radyoaktif iyot tedavisi ile tedavi edilen ve hemodiyalize giren son dönem böbrek yetmezliği hastası sunulmuştur.

Anahtar Kelimeler: Hipertiroidi, hemodiyaliz, radyoaktif iyot tedavisi

Share this Article

Applied Medical Research


ScopeMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons